Table 2.
Prevalence of the main cardiovascular risk factors and metabolic syndrome
| Group 1 n=588 |
Group 2 n=532 |
Total n=1,120 |
P-value | |
|---|---|---|---|---|
| CVRFs, mean (SD) | ||||
| Systolic blood pressure, mmHg | 125.1 (16.5) | 125.0 (17.6) | 125.0 (17.2) | 0.935 |
| Diastolic blood pressure, mmHg | 74.7 (10.8) | 74.1 (11.0) | 74.3 (10.9) | 0.362 |
| Body mass index, kg/m2 | 29.3 (5.6) | 28.6 (5.7) | 28.9 (5.7) | 0.049 |
| Glucose, mg/dL | 102.1 (32.8) | 99.7 (31.8) | 100.7 (32.2) | 0.229 |
| Triglycerides, mg/dL | 134.7 (100.9) | 130.1 (74.0) | 132.0 (86.3) | 0.394 |
| Total cholesterol, mg/dL | 202.3 (44.1) | 194.5 (40.8) | 197.8 (42.3) | 0.003 |
| HDLc, mg/dL | 54.8 (15.4) | 52.4 (16.1) | 53.4 (15.8) | 0.015 |
| LDLc, mg/dL | 121.5 (39.0) | 116.8 (34.3) | 118.8 (36.4) | 0.039 |
| Serum creatinine, mg/dL | 1.1 (0.4) | 1.1 (0.4) | 1.1 (0.4) | 0.851 |
| Metabolic syndrome | ||||
| Prevalence* | 43.9% | 34.9% | 38.6% | 0.002 |
| Components | ||||
| BMI >28.8 kg/m2 | 50.2% | 42.4% | 45.6% | 0.010 |
| BP >130/85 mmHg (or treatment) | 49.1% | 42.0% | 44.9% | 0.018 |
| Triglycerides >150 mg/dL (or treatment) | 27.1% | 24.3% | 25.4% | 0.298 |
| Fasting blood glucose >110 mg/dL | 22.7% | 19.2% | 20.6% | 0.152 |
| HDLc <40 (men) or <50 (women) mg/dL | 19.4% | 20.7% | 20.2% | 0.605 |
| Number of components | ||||
| 1 | 20.7% | 23.9% | 22.6% | |
| 2 | 22.5% | 21.8% | 22.1% | |
| 3 | 21.6% | 19.0% | 20.1% | |
| 4 | 15.9% | 12.4% | 13.8% | |
| 5 | 6.3% | 3.5% | 4.6% | 0.006 |
Notes:
*
Defined according to the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Group 1, presence of one or more negative symptoms; group 2, absence of negative symptoms.
Abbreviations: CVRFs, cardiovascular risk factors; BMI, body mass index; BP, blood pressure; HDLc, high-density lipoprotein cholesterol; LDLc, low-density lipoprotein cholesterol; SD, standard deviation.